Abys Medical intends to revolutionize surgical practice with its surgery 4.0 technology, by supporting physicians with software and artificial intelligence tools from the surgical strategy development stage to the operating room.
In March 2021, the deep tech firm based in La Rochelle began to pre-commercialize its first solution for the veterinary market. It is now preparing to launch a second system for use in orthopedic and traumatology surgery.
To facilitate its expansion, it has raised €3 million by opening its capital to institutional investment fund Océan Participations and to private investors with extensive experience in the healthcare industry.
“We aim to standardize made-to-measure orthopedic and traumatology surgery and to set a new benchmark. We want to put surgical planning and control back in the hands of surgeons to optimize patient knowledge,” says Arnaud Destainville, CEO and co-founder of Abys Medical.
Physicians can plan and model operations in detail using a unique collaborative web platform. They can simulate every sequence of an operation in 3D in less than 30 minutes after the patient’s scan. The operation is performed completely online, and there is no software to install (100% Cloud). The firm has also developed an application that provides assistance in the form of holograms during operations. The surgeon can also design customized implants for bone repair. “It is a comprehensive, interdependent system that assists the surgeon from start to finish.”
Abys Medical is already planning a second, six million euro funding round in late 2022, when it also hopes to deliver the final version of its product for human use, developed jointly with seven referral centers, mostly within the AP-HP (Paris) network. By 2024, the startup aims to offer a more comprehensive solution that makes more extensive use of artificial intelligence to automate various functions. It plans to provide diagnostic assistance with a surgical treatment proposal and to enhance the role of holograms in guiding surgeons during surgical procedures. To make these technological changes, the firm will have to raise €12 million in addition to the €3 million secured in its first funding round.
